Michael W. Dunne - Mar 25, 2022 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Director
Signature
/s/ Michael W. Dunne
Stock symbol
ITRM
Transactions as of
Mar 25, 2022
Transactions value $
$0
Form type
4
Date filed
3/29/2022, 08:00 PM
Previous filing
Jul 27, 2021
Next filing
Jun 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITRM Ordinary Shares Options Exercise $0 +10.5K +3.12% $0.00 347K Mar 25, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Restricted Share Units Options Exercise $0 -10.5K -100% $0.00* 0 Mar 25, 2022 Ordinary Shares 10.5K Direct F1, F2
transaction ITRM Restricted Share Units Award $0 +11.4K $0.00 11.4K Mar 25, 2022 Ordinary Shares 11.4K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted share units ("2021 RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the 2021 RSUs.
F2 On March 25, 2021, the reporting person was granted an award of 10,494 2021 RSUs, which vested on March 25, 2022.
F3 Each restricted share unit ("2022 RSU") represents the contingent right to receive one ordinary share upon vesting of a 2022 RSU.
F4 Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, as amended, the 2022 RSUs shall vest in full on January 1, 2023.